Results 141 to 150 of about 175,700 (308)
The prechoroidal cleft in neovascular age‐related macular degeneration
Abstract The prechoroidal cleft is a lenticular, hypo‐reflective space on optical coherence tomography imaging, located between a band of fibrovascular material underneath the retinal pigment epithelium (RPE) and Bruch's membrane. It occurs in 8%–22% of neovascular age‐related macular degeneration (nAMD) eyes, most often with macular neovascularization
Niels J. Brouwer +3 more
wiley +1 more source
Se evaluaron 62 pacientes con el diagnóstico de degeneración macular relativa a la edad, desde el mes de septiembre del año 2000 hasta el mes de agosto del año 2001.
Dora Hitchman Barada +2 more
doaj
Vitreoretinal complications and surgical outcomes in patients with X‐linked retinoschisis
Abstract Purpose X‐linked retinoschisis (XLRS) is an inherited vitreoretinal disorder characterized by macular retinoschisis. In a subgroup of patients, peripheral retinoschisis can occur, potentially leading to complications such as vitreous haemorrhage (VH) and retinal detachment (RD).
Jonathan Hensman +11 more
wiley +1 more source
Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration [PDF]
Agarwal +11 more
core +2 more sources
Abstract Purpose To evaluate long‐term outcomes of anti‐VEGF therapy for nAMD using the Polish Retinal Therapeutic Program Monitoring Registry. Methods The cohort consisted of 63 840 eyes with nAMD qualified for treatment from 2016 to 2022, with follow‐up through 31 October 2023. Long‐term follow‐up (>5 years) was conducted for 7631 eyes.
Sławomir Teper +9 more
wiley +1 more source
The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study [PDF]
John Paul SanGiovanni
openalex +1 more source
Abstract Purpose This study characterized and assessed vision‐related quality of life (VRQoL) in patients with neovascular age‐related macular degeneration (nAMD) who discontinued treatment with intravitreal anti‐vascular endothelial growth factor (anti‐VEGF), comparing them to those undergoing treatment.
Noreddin Shekho +4 more
wiley +1 more source
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study [PDF]
Jennifer Arnold +3 more
openalex +1 more source
Abstract Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.
I. Made Ferdiko Hutamadella +10 more
wiley +1 more source

